Sigrun Thorsteinsdottir, MD, PhD^1,2, Ingigerdur Sverrisdottir, MD^1,3*, Sæmundur Rögnvaldsson, MD, PhD^1,4*, Sara Ekberg, PhD^5*, Malin Hultcrantz, MD, PhD⁶, Brynjar Vidarsson, MD^4*, Pall T. Onundarson, MD⁴, Bjarni Agnarsson, MD^1,4*, Margret Sigurdardottir, MD^4*, Ingunn Thorsteinsdottir, MD, PhD^4*, Isleifur Olafsson, MD, PhD^4*, Asdis Rosa Thordardottir^1*, Jon Thorir Oskarsson, MSc^7*, Gudrun Asta Sigurdardottir^1*, Elias Eythorsson, MD, PhD^1,4*, Asbjorn Jonsson, MD^8*, Gauti Gislason, MSc^1*, Andri Olafsson^1*, Jon Kristinn Sigurdsson^1*, Thorir Einarsson Long, MD, PhD^9,10*, Brian GM Durie, MD¹¹, Stephen J. Harding, PhD¹², Ola Landgren, MD¹³, Thorvardur Jon Love, MD, PhD^1,4* and Sigurdur Y. Kristinsson, MD, PhD^1,4

¹Faculty of Medicine, University of Iceland, Reykjavik, Iceland
²Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
³Dept. of Haematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
⁴Landspitali, The National University Hospital of Iceland, Reykjavik, Iceland
⁵Red Door Analytics AB, Stockholm, Sweden
⁶Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Faculty of Medicine, University of Iceland, Reykjavik, Reykjavik, Iceland
⁸Akureyri Hospital, Akureyri, Iceland
⁹Faculty of Medicine, University of Iceland, Reykjavik, AL, Iceland
¹⁰Skåne University Hospital, Lund, Sweden
¹¹Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
¹²The Binding Site Inc., Birmingham, United Kingdom
¹³Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL

Xia Wu, MD^1*, Ping Zhou, MD, PhD^1*, Sandy W. Wong, MD², Benjamin Rosenthal, MD^3*, Alfred Chung, MD⁴, Denis Toskic, BS^5*, Stephanie Scalia^1* and Raymond Comenzo, MD⁶

¹Tufts Medical Center, Boston, MA
²Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
³University of Pennsylvania, Philadelphia
⁴Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
⁵The John Davis Myeloma and Amyloid Program, Tufts Medical Center, Revere, MA
⁶Box 826, Tufts Medical Center, Boston, MA

Camille Tessier, MD¹, Richard Leblanc, MD, FRCPC^2,3, Jean Roy, MD^4,5, Sabrina Trudel, MD^6,7*, Julie Cote, MD^8,9, Marc Lalancette, MD^10,11, Jean-Samuel Boudreault, MD^12,13, Emilie Lemieux-Blanchard, BSc, MD^3,14, Rayan Kaedbey, MD^15,16 and Michel Pavic, MD^17,18*

¹University of Sherbrooke, Montreal, QC, Canada
²Maisonneuve-Rosemont Hospital, Montreal, QC, CAN
³University of Montreal, Montreal, QC, Canada
⁴Maisonneuve-Rosemont Hospital, Montreal, Qc, CAN
⁵Université de Montréal, Montréal, QC, Canada
⁶University of Sherbrooke, Sherbrooke, QC, Canada
⁷Charles LeMoyne Hospital, Greenfield Park, QC, Canada
⁸CHU de Québec, Quebec, QC, Canada
⁹Laval University, Quebec, QC, Canada
¹⁰CHUQ Pavillon Hotel-Dieu, Quebec, QC, CAN
¹¹Centre intégré de cancérologie, CHU de Québec - Université Laval, Québec, QC, Canada
¹²Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada
¹³University of Montreal, Montreal, Qc, CAN
¹⁴CHUM, Montreal, QC, CAN
¹⁵McGill University, Montreal, QC, Canada
¹⁶Jewish General Hospital, Montréal, QC, Canada
¹⁷University of Sherbrooke, Sherbrooke, CAN
¹⁸Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke, QC, Canada

Donghua He^1*, Xinyi Meng^2*, Jingsong He^3*, Wenjun Wu, MD^4*, Jinuo Wang, MD^5*, Chunting Zhu^2*, Xiaoyan Han^6*, Yi Zhao^7*, Gaofeng Zheng, MD^4*, Yi Li^8*, Xing Guo^9*, Qingxiao Chen, MD^6*, Fangshu Guan^5* and Zhen Cai^7*

¹The First Affiliated Hospital, College of Medicine, Zhejiang University, HANGZHOU, ZHEJIANG, CHN
²The First Affiliated Hospital of Zhejiang University, College of Medicine, China, Hangzhou, China
³The Department of Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Hangzhou, China
⁵the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁶Department of Hematology and Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
⁷Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁸The First Affiliated Hospital of Zhejiang University, College of Medicine, China, Hangzhou, OH, China
⁹The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, CHN

Efstathios Kastritis, MD^1*, Panagiotis Malandrakis, MD^1*, Ioannis V Kostopoulos, Msc. PhD^2*, Ioannis Ntanasis-Stathopoulos, MD, PhD^1*, Irene Solia, MD^1*, Despina Fotiou, MD, PhD^1*, Vasiliki Spiliopoulou, MD^1*, Foteini Theodorakakou, MD^1*, Rodanthi Syrigou, MD^1*, Magdalini Migkou, MD, PhD^1*, Maria Roussou, MD^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Nikolaos Kanellias, MD, PhD^1*, Nikoletta-Aikaterini Kokkali^1*, Alexandra Papadimou^1*, Kostantina Taouxi^1*, Ourania Tsitsilonis, MD, PhD^2*, Maria Gavriatopoulou, MD, PhD^1*, Meletios A. Dimopoulos³ and Evangelos Terpos, MD, PhD⁴

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Department of Biology, National and Kapodistrian University of Athens, School of Science, Athens, Greece
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece

Cara Rosenbaum, MD¹, Michaela Liedtke, MD², Paul Christos, DrPH, MS^3*, Hyemin Kim, MD^4*, Kathleen Pogonowski, RN^4*, Natalie Agudo, RN^4*, Bruna Barroso, BSN, RN^5*, Anthony Shelton, RN, BS^6*, Samantha Reilly, BS^5*, Courtney Gadbois, BS^7*, John Mark Sloan, MD⁸, Vaishali Sanchorawala, MD⁹ and Anita D'Souza, MD, MS¹⁰

¹Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
²Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA
³Division of Biostatics, Department of Population Heath Sciences, Weill Cornell, New York
⁴Weill Cornell Medicine, New York
⁵Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston
⁶Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁷Medical College of Wisconsin, Milwaukee
⁸Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁹Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
¹⁰The Medical College of Wisconsin Inc, Milwaukee, WI

Laurent Garderet, MD, PhD^1*, Luuk Gras Sr., MD, PhD^2*, Linda Koster^3*, Montserrat Rovira, MD, PhD^4*, Laure Vincent, MD^5*, Guido Kobbe, MD^6*, Srinivas Pillai^7*, Dries Deeren, MD⁸, Martin Kaufmann, MD⁹, Jurgen Kuball, MD¹⁰, Hakan Ozdogu, MD^11*, Maria Jesús Pascual^12*, Jakob R. Passweg, MD, MS¹³, Adam Rye^14*, Urpu Salmenniemi^15*, John Snowden, MD^16*, Thomas Stauffer Larsen^17*, Xavier Leleu, MD¹⁸, Lauris Gastaud^19*, Joanna Drozd-Sokolowska, MD, PhD^20*, Kavita Raj, MD, PhD²¹, Meral Beksac, MD²², Stefan Schonland^23*, Patrick John Hayden, MD²⁴ and Donal P McLornan, MD, PhD^21*

¹Hôpital la pitié salpetriere, Paris, FRA
²EBMT Statistical Unit, Leiden, Netherlands
³EBMT Leiden Study Unit, Leiden, Netherlands
⁴Hospital clinic, Barcelona, Spain
⁵Department of Clinical Hematology, Montpellier University Hospital Center, Montpellier, France
⁶Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany
⁷University hospital of North Staffordshire, Stoke, United Kingdom
⁸AZ Delta, Roeselare, BEL
⁹Department of Hematology, Oncology and Palliative Care, Robert Bosch Hospital, Stuttgart, Germany
¹⁰Utrecht University, University Medical Centre, Utrecht, Netherlands
¹¹Baskent University Hospital, Adana, TUR
¹²Hospital Regional de Málaga, Malaga, Spain
¹³Department of Hematology University Hospital of Basel, Basel, Switzerland
¹⁴Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, GBR
¹⁵Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
¹⁶Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
¹⁷Department of Hematology, Odense University Hospital, Odense, Denmark
¹⁸Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France
¹⁹Centre Antoine Lacassagne, Tourrettes-sur-Loup, France
²⁰Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland
²¹University College London Hospitals NHS Trust, London, United Kingdom
²²Ankara University School of Medicine, Hematology Department, Ankara, Turkey
²³University of Heidelberg, Heidelberg, Germany
²⁴Department of Haematology, Trinity College Dublin, St. James’s Hospital, Dublin, Ireland

Efstathios Kastritis, MD^1*, Vasiliki Spiliopoulou, MD^1*, Foteini Theodorakakou, MD^1*, Despina Fotiou, MD, PhD^1*, Evangelos Eleutherakis-Papaiakovou, MD^1*, Magdalini Migkou, MD, PhD^1*, Maria Roussou, MD^1*, Panagiotis Malandrakis, MD^1*, Ioannis Ntanasis-Stathopoulos, MD, PhD^1*, Nikolaos Kanellias, MD, PhD^1*, Rodanthi Syrigou, MD^1*, Asimina Papanikolaou, MD^2*, Hariklia Gakiopoulou^3*, Maria Gavriatopoulou, MD, PhD^1*, Evangelos Terpos, MD, PhD⁴ and Meletios A. Dimopoulos⁵

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Hematopathology Department, Evangelismos General Hospital, Athens, Greece
³1st Department of Pathology, National & Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece
⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece

Andrew Staron, MD^1,2, Eric J Burks, MD^2,3*, Raphael E Szalat, MD, PhD¹ and Vaishali Sanchorawala, MD^1,2

¹Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
³Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA

Alessandra Trojani, PhD^1*, Alessandro Beghini^2*, Luca Emanuele Emanuele Bossi^1*, Marta Rachele Stefanucci^2*, Cassandra Palumbo^1*, Antonino Greco^3*, Annamaria Frustaci, MD^1*, Barbara Di Camillo^4*, Marco Montillo¹ and Roberto Cairoli, MD^1*

¹Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
²Department of Health Sciences, University of Milan, Milan, Italy
³A.R.N.A.S. Ospedali Civico Di Cristina Benfratelli, Palermo, Italy
⁴Department of Information Engineering, University of Padova, Padova, Italy

Danai Dima, MD¹, Fauzia Ullah, MD^1*, Serhan Unlu, MD^1*, Diana Basali, MD¹, Mahir Khan, MD^1*, Abdullah Saeed Khan, MBBS^1*, Xuefei Jia, MS^2*, Majid Jaberi-Douraki^3*, Beth M. Faiman, PhD, CNP¹, Sandra Mazzoni, DO^1*, Louis S. Williams, MD¹, Christy J. Samaras, DO¹, Jason Valent, MD¹, Faiz Anwer, MD¹, Jack Khouri, MD¹ and Shahzad Raza, MD^1*

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Biostatistics and Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH
³Department of Mathematics, Kansas State University, DATA Consortium, Computational Comparative Medicine, Olathe, KS

Jahanzaib Khwaja¹, Joshua Bomsztyk^2*, Ceri Bygrave, MD, FRCPath, MPhil^3*, Adam Forbes^4*, Senthilkumar Durairaj^5*, Savio Fernandes^6*, James Taylor^7*, Pamela Paterson^8*, Gillian Brearton^9*, Charles Crawley, MD^10*, Oonagh Sheehy^11*, Rachel Brown^12*, Richard Soutar, MD^13*, Mamta Garg, MD, MBBS, FRCP, FRCPath^14*, Andrzej Rydzewski^15*, Krzysztof Jamroziak^16*, Emma Dowling^1*, Nuno Correia^1*, Sarah Worthington^1*, Shameem Mahmood^1,2* and Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath^1,2

¹University College London Hospitals, London, United Kingdom
²Royal Free London Hospital, National Amyloid Centre, London, United Kingdom
³Haematology, University Hospital Wales, Cardiff, United Kingdom
⁴Royal Cornwall Hospital NHS Trust, Truro, United Kingdom
⁵Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom
⁶The Dudley Group NHS Foundation Trust, Dudley, United Kingdom
⁷Rotherham NHS Foundation Trust, Rotherham, United Kingdom
⁸Monklands Hospital, Lanarkshire, United Kingdom
⁹Clatterbridge Cancer Centre, Liverpool, United Kingdom
¹⁰Addenbrookes Hospital, Cambridge, United Kingdom
¹¹Belfast Health and Social Care Trust, Belfast, United Kingdom
¹²Manchester University NHS Foundation Trust, Manchester, United Kingdom
¹³Glasgow Royal Infirmary, Glasgow, United Kingdom
¹⁴University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
¹⁵The National Institute of Medicine of the Ministry of Interior and Administration, Warsaw, Poland
¹⁶Institute of Hematology and Blood Transfusion, Warsaw, Poland

Vaishali Sanchorawala, MD¹, Ashutosh D Wechalekar, MBBS, MD, FRCP, FRCPath, DM^2*, Efstathios Kastritis, MD^3*, Giovanni Palladini, MD, PhD^4,5, Stefan Schönland, MD^6*, Raymond Comenzo, MD⁷, Anita D'Souza, MD, MS⁸, Jack Khouri, MD⁹, Victor Jimenez-Zepeda, MD^10*, Katherine Ingrid Sprinz, PhD^11*, Heather Hao, MD^12*, Wenying Huang, MD^13*, Laura Governale Aubrey, MD^13* and Morie A. Gertz, MD¹⁴

¹Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²National Amyloidosis Centre UCL Medical School (Royal Free Campus), Royal Free Hospital, London, United Kingdom
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Amyloidosis Research and Treatment Center, University of Pavia, Pavia, Italy
⁵Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁶Universitätsklinikum Heidelberg, Heidelberg, Germany
⁷Box 826, Tufts Medical Center, Boston, MA
⁸The Medical College of Wisconsin Inc, Milwaukee, WI
⁹Department of Medicine, Cleveland Clinic, Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
¹⁰University of Calgary, Calgary, AB, Canada
¹¹Prothena Biosciences Inc, South San Francisco, CA
¹²Prothena Biosciences, Inc., South San Francisco
¹³Prothena Biosciences, Inc., South San Francisco, CA
¹⁴Department of Medicine, Division of Hematology,, Mayo Clinic, Rochester, MN

Andrew Staron, MD^1,2, Lisa M. Mendelson, NP^2*, Tracy Joshi, DNP^2* and Vaishali Sanchorawala, MD^1,2

¹Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA

Eli Muchtar, MD¹, Giovanni Palladini, MD, PhD², Stefan Schonland^3*, Angela Dispenzieri, MD⁴, Brendan Wisniowski, MD^5*, Giampaolo Merlini, MD^2,6*, Paolo Milani, MD, PhD^7,8, Ute Hegenbart^9*, Tobias Dittrich^10*, Efstathios Kastritis, MD^11*, Meletios A. Dimopoulos¹², Vaishali Sanchorawala, MD¹³, Raphael E Szalat, MD, PhD¹³, Michaela Liedtke, MD¹⁴, Mani Gupta, MBBS^15*, Heather Landau, MD¹⁶, Suzanne Lentzsch, MD, PhD¹⁷, Michael Sang Hughes, MD¹⁸, Maria Teresa Cibeira López^19*, Joan Bladé, MD, PhD^20*, Shaji Kunnathu Kumar, MD²¹, Ashutosh D. Wechalekar, MBBS, DM, FRCP, FRCPath²² and Morie A Gertz, MD^4*

¹Mayo Clinic, Rochester, Minnesota, Rochester, MN
²Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
³University of Heidelberg, Heidelberg, Germany
⁴Mayo Clinic, Rochester, MN
⁵National Amyloidosis Centre, University College London, Royal Free Hospital Campus, London, United Kingdom
⁶University of Pavia, Pavia, ITA
⁷Department of Molecular Medicine, University of Pavia, Pavia, Italy
⁸Foundation IRCCS Policlinico San Matteo, Pavia, Italy
⁹Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Neckargem??nd, Baden-W., Germany
¹⁰Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany
¹¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
¹³Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
¹⁴Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA
¹⁵Stanford Amyloid Center, Stanford University, Stanford, CA
¹⁶Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁷Division of Hematology & Oncology, Columbia University Medical Center, New York, NY
¹⁸Columbia University Medical Center, New York, NY
¹⁹University of Barcelona, Barcelona, Spain
²⁰Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona and GEM/PETHEMA, Barcelona, Spain
²¹Division of Hematology, Mayo Clinic, Rochester, MN
²²University College London Hospitals, London, United Kingdom

Romain Stemmler^1*, Marion Malphettes^2*, Lionel Galicier^2,3*, Laurence Gerard, MD^4*, Veronique Meignin, MD^5*, David Boutboul, MD, PhD^6* and Eric Oksenhendler^2*

¹Clinical Immunology, Hôpital Saint-Louis, Paris, France
²Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, France
³Centre de Réference National Maladie de Castleman, Paris, France
⁴Hôpital Saint-Louis, Paris, France
⁵Pathology, Hopital Saint-Louis, PARIS, FRA
⁶Service d'Immunopathologie Clinique, Saint Louis hospital, AP-HP, Paris, Paris, France

Zarouki Mouktadi, MSc^1*, Paul-Henri Diemont^2*, Luciano Di Stefano, PhD^3*, Vincent Bonifay, PhD^3*, Sebastien Bender, PhD^2*, Virginie Pascal, MD, PhD^2,4*, Christophe Sirac^2*, Murielle Roussel, MD^5*, Caroline Rougé Dubroc^3* and Pierre Sonigo^3*

¹SEBIA, Lisses, AL, France
²CNRS UMR 7276, INSERM UMR 1262, Université de Limoges, Limoges, France
³SEBIA, Lisses, France
⁴Laboratory of Immunology and Immunogenetics, Centre Hospitalier Universitaire de Limoges, Limoges, France
⁵Hematology department, Centre Hospitalier Universitaire de Limoges, Limoges, France

Harshita Rajasekariah, MD^1,2, Georgia McCaughan, BMedSc MBBS MMed (Clin Epi) FRACP FRCPA^2,3*, Chun Kei Kris Ma, BSc MBBS PhD FRACP FRCPA^4,5, Natasha Gorrie, MBBS FRACP^2,6,7*, Samuel Milliken, MBBS FRACP FRCPA^2,3*, David Ma, MBBS MD FRACP FRCPA^2,3*, Keith Fay, MBChB, FRACP, FRCPA^3,8*, Barbara Withers, BSc MBBS PhD FRACP FRCPA^2,3*, Nada Hamad, BSc MSc MBBS FRACP FRCPA^2,3, Samuel Birch, MBBS(Hons) FRACP^6*, Anne Keogh, MBBS MD FRACP FCSANZ FPVRI^2,6,7*, Andrew Jabbour, BSc(Med) MBBS(Hons) PhD FRACP FCSANZ^2,6,7*, Christopher Hayward, BMedSc MBBS (Hons) MD FRACP FCSANZ^2,6,7*, Peter Macdonald, MBBS MD PhD FRACP FCSANZ^2,6,7* and John Moore, MBBS MD FRACP FRCPA^2,3

¹Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, Australia
²The University of New South Wales, Kensington, NSW, Australia
³Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
⁴The University of Sydney, Camperdown, NSW, Australia
⁵Department of Haematology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia
⁶Cardiology Department, St Vincent's Hospital, Darlinghurst, NSW, Australia
⁷Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia
⁸Department of Haematology, Royal North Shore Hospital, St Leonards, NSW, Australia

Grace M. Ferri, MD¹, Josue Villegas Galaviz, MD^2,3*, Tinuola Ajayi, MD^1*, Richard Giadone, PhD^4*, George J. Murphy, PhD^4,5, Andrew Staron, MD^5,6, Frederick L. Ruberg, MD^2,6*, Vaishali Sanchorawala, MD^5,6 and Camille V. Edwards, MD^4,5,6

¹Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²Section of Cardiovascular Medicine, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
³Section of Cardiovascular Medicine, Department of Medicine, East Tennessee State University, Johnson City, TN
⁴Center for Regenerative Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA
⁵Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
⁶Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA

Raphael E Szalat, MD, PhD¹, Srikanth Talluri, PhD^2*, Charlotte M Royer^3*, Sherry Wong^4*, Gareth Morgan, PhD⁵, Vaishali Sanchorawala, MD¹, Mehmet K. Samur, PhD^6,7 and Nikhil C Munshi, MD^8*

¹Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA
²Harvard Medical School, West Roxbury, MA
³Boston University Medical Center, Boston University Medical Center, Boston, MA
⁴Boston University Amyloidosis Center, Boston University, Boston, MA
⁵Boston University School of Medicine, Boston, MA
⁶Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA
⁷Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
⁸Dana-Farber Cancer Institute, Boston, MA